Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies
Ankylosing Spondylitis Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Ankylosing Spondylitis pipeline products.
The Ankylosing Spondylitis pipeline guide presents complete overview of drugs currently being developed for Ankylosing Spondylitis. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).
Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Ankylosing Spondylitis pipeline candidate. Research and Development progress along with latest news related to each of the Ankylosing Spondylitis pipeline candidates is included.
Major companies participating in therapeutic development of Ankylosing Spondylitis are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.
Amid strong interest for cure of Ankylosing Spondylitis from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Ankylosing Spondylitis clinical and pre clinical products.
The report assists in identifying potential upcoming companies and drugs in Ankylosing Spondylitis pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.
Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.
Scope of Ankylosing Spondylitis pipeline report includes
Panorama of Ankylosing Spondylitis pipeline markets including statistics on therapeutic drugs and companies involved
Ankylosing Spondylitis Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered
Ankylosing Spondylitis pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study
Overview of companies participating in Ankylosing Spondylitis pipeline with short introduction to their businesses and pipeline projects
For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.
Research and Development progress and trial details, results wherever available, are also included in the pipeline study
The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Ankylosing Spondylitis pipeline therapeutics
Reasons to Buy Get clear understanding of the entire Ankylosing Spondylitis pipeline, with details on active projects
Get in detail information of each product with updated information on each project along with key milestones
Know the list of companies participating in global Ankylosing Spondylitis pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data
Get trial information for each pipeline product under development
Understand the pipeline structure in terms of mechanism of Action, phase and company
Please Note: The report will be delivered in 2 working days after purchase
Our reports have been used by over 10K customers, including:
Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment.The company’s products include multilisa SSC, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
Anatomic Pathology Market Report Overview Anatomic Pathology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anatomic Pathology market types and applications. It is a focused study on Anatomic Pathology market space including global...
Pathology Devices Market Report Overview Pathology Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pathology Devices market types and applications. It is a focused study on Pathology Devices market space including global and...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Application (Drug Discovery & Development, Academic Research), By End-use, By Region, And Segment Forecasts, 2021 - 2028 Digital Pathology Market Growth & Trends The global digital pathology market...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
The current practice of medical education and methods of performing surgery and therapy suffer from limitations such as scarcity of subjects to practice on, suboptimal surgical precision, and therapy-related issues including medication misuse and ineffectiveness of the drugs to treat the conditions. Moreover, the outbreak of COVID-19 pandemic...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the anatomical pathology equipment and consumables market are Epridea, F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Sakura Finetek, Agilent Technologies, Danaher Corporation, Bio SB, BioGenex Laboratories, and Quest Diagnostics Incorporated. The global anatomic pathology equipment and consumables...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
Cause-Specific Mortality Rate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.